The companies have signed a semiexclusive licensing agreement for Protagen’s BICD2, a novel autoantigen and the first proprietary biomarker discovered by the company employing its SeroTag technology.
Read More
This month’s issue features new products from such companies as Advanced Instruments, Bio-Rad Laboratories, Sekisui Diagnostics, and Wheaton.
Read More
Analyzing real-world clinical data may transform cancer treatment.
Read More
The simple blood test identifies individuals who are at risk of experiencing a heart attack, and for whom early intervention can help.
Read More
A molecular diagnostic from Luminex is the latest to receive emergency use authorization to detect Zika virus.
Read More